Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of Maviret in Malmö Needle Exchange Program participants with hepatitis C
2017-002008-28Phase 4Active
- Sponsor
- Region Skåne
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of glecaprevir + pibrentasvir in hepatitis C virus infection, sponsored by Region Skåne. Primary endpoint: SVR12. Started Nov 2017; status: active.
02
Drugs
glecaprevir + pibrentasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2017-002008-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002008-28.